Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment

Acta Biochim Biophys Sin (Shanghai). 2015 Aug;47(8):647-53. doi: 10.1093/abbs/gmv049. Epub 2015 Jun 9.

Abstract

Excessive exposure to infrasound, a kind of low-frequency but high-intensity sound noise generated by heavy transportations and machineries, can cause vibroacoustic disease which is a progressive and systemic disease, and finally results in the dysfunction of central nervous system. Our previous studies have demonstrated that glial cell-mediated inflammation may contribute to infrasound-induced neuronal impairment, but the underlying mechanisms are not fully understood. Here, we show that cannabinoid (CB) receptors may be involved in infrasound-induced neuronal injury. After exposure to infrasound at 16 Hz and 130 dB for 1-14 days, the expression of CB receptors in rat hippocampi was gradually but significantly decreased. Their expression levels reached the minimum after 7- to 14-day exposure during which the maximum number of apoptotic cells was observed in the CA1. 2-Arachidonoylglycerol (2-AG), an endogenous agonist for CB receptors, reduced the number of infrasound-triggered apoptotic cells, which, however, could be further increased by CB receptor antagonist AM251. In animal behavior performance test, 2-AG ameliorated the infrasound-impaired learning and memory abilities of rats, whereas AM251 aggravated the infrasound-impaired learning and memory abilities of rats. Furthermore, the levels of proinflammatory cytokines tumor necrosis factor alpha and interleukin-1β in the CA1 were upregulated after infrasound exposure, which were attenuated by 2-AG but further increased by AM251. Thus, our results provide the first evidence that CB receptors may be involved in infrasound-induced neuronal impairment possibly by affecting the release of proinflammatory cytokines.

Keywords: cannabinoid receptors; infrasound; neuronal impairment; proinflammatory cytokines; vibroacoustic disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acids / pharmacology
  • Cannabinoid Receptor Agonists / pharmacology
  • Cannabinoid Receptor Antagonists / pharmacology
  • Endocannabinoids / pharmacology
  • Glycerides / pharmacology
  • Hippocampus* / metabolism
  • Hippocampus* / physiopathology
  • Hippocampus* / radiation effects
  • Inflammation Mediators / metabolism
  • Interleukin-1beta / metabolism
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • Rats
  • Receptors, Cannabinoid / biosynthesis*
  • Ultrasonic Waves* / adverse effects

Substances

  • Arachidonic Acids
  • Cannabinoid Receptor Agonists
  • Cannabinoid Receptor Antagonists
  • Endocannabinoids
  • Glycerides
  • Inflammation Mediators
  • Interleukin-1beta
  • Piperidines
  • Pyrazoles
  • Receptors, Cannabinoid
  • AM 251
  • glyceryl 2-arachidonate